These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Anaphylactic shock: the advantages of intra aortic balloon counter pulsation for the treatment of heart failure. Yeguiayan JM; Ravisy J; Lenfant F; Pillet M; Freysz M Resuscitation; 2007 Mar; 72(3):493-5. PubMed ID: 17141395 [TBL] [Abstract][Full Text] [Related]
67. Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectoris. Liberts EA; Willoughby SR; Kennedy JA; Horowitz JD Eur J Pharmacol; 2007 Mar; 560(1):49-55. PubMed ID: 17292880 [TBL] [Abstract][Full Text] [Related]
68. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. Smith B; Forkner E; Zaslow B; Krasuski RA; Stajduhar K; Kwan M; Ellis R; Galbreath AD; Freeman GL Am J Manag Care; 2005 Nov; 11(11):701-13. PubMed ID: 16268753 [TBL] [Abstract][Full Text] [Related]
69. Enhanced external counterpulsation: a new modality in the treatment of angina and heart failure. Arora RR; Shah AG J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):271-3. PubMed ID: 17220474 [No Abstract] [Full Text] [Related]
70. [Treatment of heart patients with antithyroids or iodine 131]. BRUNE DF; CHAILLET JL; SCHWARZ F Ned Tijdschr Geneeskd; 1963 Mar; 107():584-9. PubMed ID: 14016270 [No Abstract] [Full Text] [Related]
71. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris. Saha S; Berglund M; Sylvén C; Gordon A; Agewall S Int J Cardiol; 2008 Jan; 123(2):195-6. PubMed ID: 17320208 [TBL] [Abstract][Full Text] [Related]
72. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE). Koren MJ; Crager MR; Sweeney M J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881 [TBL] [Abstract][Full Text] [Related]
73. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Bradshaw PJ; Jamrozik K; Gilfillan I; Thompson PL Am Heart J; 2004 Jun; 147(6):1047-53. PubMed ID: 15199354 [TBL] [Abstract][Full Text] [Related]
74. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction. Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330 [TBL] [Abstract][Full Text] [Related]
75. [On a new theophylline. Its importance in the treatment of anginal pain]. BOURDE C; BOUSQUET R Vie Med; 1962 Nov; 43():137-44. PubMed ID: 14014428 [No Abstract] [Full Text] [Related]
76. [Total thyroidectomy in non-thyroid congestive heart failure and angina pectoris]. BOLIVAR J; RABINA P Rev Cubana Cardiol; 1949; 10(3):145-86. PubMed ID: 15393761 [No Abstract] [Full Text] [Related]
77. The use of a mercurial diuretic (with theophylline) in patients with angina decubitus. Preliminary clinical observations. PAUL O Med Clin North Am; 1951 Jan; 35(1):63-71. PubMed ID: 14796109 [No Abstract] [Full Text] [Related]
79. Angina pectoris and rehabilitation in geriatric patients. EISFELDER HW; FICARRA BJ; AMES L J Am Geriatr Soc; 1960 Jan; 8():62-5. PubMed ID: 13819777 [No Abstract] [Full Text] [Related]
80. Enhanced theophylline blood levels obtained after ingestion of choline theophyllinate as compared to aminophylline with or without aluminum hydroxide. GAGLIANI J; DE GRAFF AC; KUPPERMAN HS Int Rec Med Gen Pract Clin; 1954 May; 167(5):251-5. PubMed ID: 13162622 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]